Home / Content / B2B Connect / Pharma / Lupin launches pain killer drug morphine sulfate tablet in US

Lupin launches pain killer drug morphine sulfate tablet in US

Tablet is a generic version of MS Contin ER, which had annual US sales of $ 282.9 mn

Premium

Last Updated : Jan 17 2017 | 11:12 AM IST

Lupin Limited has launched its morphine sulfate ER tablet (in strengthen of 15 mg, 30 mg, 60 mg, 100 mg and 200 mg) having received an approval from the US Food and Drug Administration (FDA). The tablet is a generic version of Purdue Pharma’s MS Contin ER.

Morphine sulfate ER tablet is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

According to IMS MAT September 2016 data, MS Contin ER tablet had US sales of $ 282.9 million.

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in